Skip to main content

Jeff Lagasse

By Jeff Lagasse | 04:25 pm | May 15, 2023
Medicare annual spending on lecanemab's medication costs alone would place it among the most expensive Part B medications.
By Jeff Lagasse | 01:12 pm | May 15, 2023
Even conditions with a low average cost, such as behavioral health and orthopedic issues, can reach over $1 million, data shows.
By Jeff Lagasse | 04:09 pm | May 12, 2023
Participants have the chance to consult with a nurse practitioner for referrals and advice.
By Jeff Lagasse | 12:44 pm | May 12, 2023
Humana framed the partnerships as part of a push to expand value-based care across its slate of home health services.
By Jeff Lagasse | 09:28 pm | May 11, 2023
The complainant alleged that MCR Health failed to provide her with auxiliary aids and services when attending her husband's appointment.
By Jeff Lagasse | 02:28 pm | May 11, 2023
While the short-term risk of being hit with a medical liability lawsuit is low, the risk increases over time, the survey showed.
By Jeff Lagasse | 12:51 pm | May 11, 2023
Modeling showed per-visit reimbursement that was 6% lower for Black children and 3% lower for Hispanic children.
By Jeff Lagasse | 11:22 am | May 11, 2023
The 17-health-system agreement is meant to provide opportunities for prospective hires who have faced barriers to employment.
By Jeff Lagasse | 01:39 pm | May 10, 2023
Seventy-two percent expect to keep things as they had been, 6% expect to be more selective, and 22% don't know how they will move forward.
By Jeff Lagasse | 12:40 pm | May 10, 2023
While the plan fell short of Oscar Health's expectations, CEO Bertolini noted that the company did turn a profit in the first quarter.